RecruitingNot ApplicableNCT04664946

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT)

Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With No Reperfusion Therapy (INSIST-NRT): One Single Center, Safety and Feasibility Study

Sponsor

Hui-Sheng Chen

Enrollment

30 participants

Start Date

Dec 1, 2020

Study Type

INTERVENTIONAL

Conditions

Ischemic Stroke Neuroprotection

Summary

To explore the safety and feasibility of intra-arterial neuroprotective strategy in acute ischemic stroke patients who missed recanalization operation.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Intra-arterial administration of neuroprotective agents for people with ischemic stroke and neuroprotection. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIntra-arterial administration of neuroprotective agents

Intra-arterial administration of 3-n-butylphthalide for 24 hours via microcatheter at 17.36 ug/min.

Locations(1)

Department of Neurology, General Hospital of Northern Theater Command

Shenyang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04664946

Related Trials

Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

NCT0713931437 locations

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

NCT0506521666 locations

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

NCT0491621031 locations

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

NCT0664924046 locations

Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)

NCT05880524